Catalogo dei prodotti della ricerca

ZINGONI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.690
EU - Europa 1.584
AS - Asia 526
AF - Africa 38
SA - Sud America 31
Totale 5.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.666
IT - Italia 773
DE - Germania 228
SG - Singapore 185
IN - India 154
CN - Cina 123
UA - Ucraina 86
FR - Francia 81
NL - Olanda 79
FI - Finlandia 77
SE - Svezia 73
GB - Regno Unito 44
RU - Federazione Russa 36
BG - Bulgaria 34
TG - Togo 31
KR - Corea 26
AR - Argentina 15
CA - Canada 15
IE - Irlanda 15
AT - Austria 14
BE - Belgio 10
IR - Iran 9
CH - Svizzera 8
ES - Italia 8
RO - Romania 8
BZ - Belize 7
HK - Hong Kong 7
BR - Brasile 6
JP - Giappone 6
TR - Turchia 6
CL - Cile 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DK - Danimarca 3
IL - Israele 3
NG - Nigeria 3
PE - Perù 3
TW - Taiwan 3
ZA - Sudafrica 3
AL - Albania 2
GR - Grecia 2
BA - Bosnia-Erzegovina 1
MU - Mauritius 1
MX - Messico 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
TH - Thailandia 1
Totale 5.869
Salva come PNG Salva come JPEG
Città #
Fairfield 585
Ashburn 391
Rome 359
Woodbridge 266
Houston 248
Seattle 237
Chandler 233
Ann Arbor 223
Wilmington 198
Cambridge 169
Singapore 103
Princeton 90
Dearborn 79
Beijing 73
Paris 70
Fasano 64
San Paolo di Civitate 63
Plano 62
Lawrence 56
Boston 36
Millbury 36
San Diego 34
Sofia 34
Lomé 31
Jacksonville 30
Andover 27
Helsinki 26
Falls Church 21
New York 21
San Jose 20
Boardman 18
Milan 16
Federal 14
Phoenix 14
Tivoli 14
Fremont 13
Washington 13
Dublin 12
Hefei 12
Brussels 10
Norwalk 10
Pune 10
Vienna 10
Amsterdam 9
Des Moines 8
Santa Clara 8
Belize City 7
Hangzhou 7
Key Biscayne 7
Madrid 7
Mannheim 7
Toronto 7
London 6
Palermo 6
Parma 6
Zanjan 6
Berlin 5
Bologna 5
Bremen 5
Dongjak-gu 5
Frankfurt am Main 5
Grafing 5
Kunming 5
Nanjing 5
Nettuno 5
Redwood City 5
Sacramento 5
Southend 5
Ancona 4
Artena 4
Atlanta 4
Bern 4
Brescia 4
Bühl 4
Camerino 4
Castel Gandolfo 4
Dallas 4
Fenile 4
Monterotondo 4
Naples 4
Santiago 4
Seongbuk-gu 4
Bellevue 3
Buffalo 3
Chiba 3
Den Helder 3
Duarte 3
Hebei 3
Istanbul 3
Leawood 3
Oakville 3
Pohang 3
Pontelandolfo 3
Rimini 3
Rødovre Municipality 3
San Mateo 3
San Valentino Torio 3
São Paulo 3
Taipei 3
Albuquerque 2
Totale 4.311
Salva come PNG Salva come JPEG
Nome #
Immune complexes exposed on mast cell-derived nanovesicles amplify allergic inflammation 181
Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70/TLR2/NF-kB axis 157
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells 151
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells. role of cMYC-IRF4-miR-125b interplay 151
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma 138
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA. Dual role in cancer immunosurveillance 128
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation 127
Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms 120
Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice 119
Interplay of protein corona and immune cells controls blood residency of liposomes 114
Drug-induced senescent Multiple Myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL-15 trans-presentation 113
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in multiple myeloma. modulation by bromodomain and Extra-Terminal (BET) protein inhibitors 112
Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells. 100
Targeting NKG2D and NKp30 ligands shedding to improve NK cell–based immunotherapy 98
Bone marrow stromal cell-derived IL-8 upregulates PVR expression on multiple myeloma cells via NF-kB transcription factor 95
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression 94
Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment. 91
Cancer extracellular vesicles as novel regulators of NK cell response 91
c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells. 90
NKG2D and its ligands: one for all, all for one 90
High expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma 90
DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction 89
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients 87
null 87
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis 86
Translating the anti-myeloma activity of Natural Killer cells into clinical application 85
Key role of the CD56lowCD16low Natural Killer cell subset in the recognition and killing of Multiple Myeloma cells 84
MICA-129 dimorphism and soluble MICA are associated with the progression of multiple myeloma 83
Cancer Exosomes as Conveyors of Stress-Induced Molecules: New Players in the Modulation of NK Cell Response. 83
Recognition of a carbohydrate xenoepitope by human NKRP1A (CD161) 81
The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells 81
Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. 78
Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8(+) T cells 77
Isolation and chromosomal localization of GPR31, a human gene encoding a putative G protein-coupled receptor 75
ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype 71
Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells 70
Natural killer (NK) cells from killers to regulators: Distinct features between peripheral blood and decidual NK cells 68
High-efficient lentiviral vector-mediated gene transfer into primary human NK cells 66
Natural killer cell response to chemotherapy-stressed cancer cells: Role in tumor immunosurveillance. 66
An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation 66
NK cell regulation of T cell-mediated responses 63
Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7 63
Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3 63
Modulation of T Cell-Mediated Immune Responses by Natural Killer Cells 62
Hepatitis C virus direct-acting antivirals therapy impacts on extracellular vesicles microRNAs content and on their immunomodulating properties 62
null 62
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma 61
Post-translational mechanisms regulating NK cell activating receptors and their ligands in cancer: Potential targets for therapeutic intervention 61
Opsonin-deficient nucleoproteic corona endows unPEGylated liposomes with stealth properties in vivo 61
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity 60
Molecular cloning and expression of cDNA encoding the rat UDP-N-Acetylglucosamine:-6-D Mannoside ?-1,2-N-Acetylglucosaminyltransferase II 60
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation 60
Human Leukocyte Antigen E Contributes to Protect Tumor Cells from Lysis by Natural Killer Cells 59
The activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma (MM) cells. 57
NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2 57
CD94/NKG2-A inibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. 56
NKG2D ligand shedding in response to stress: role of ADAM10 54
Natural killer cells as regulators of T cell-mediated immune responses. 53
CD69-triggered ERK activation and functions are negatively regulated by CD94/NKG2A inhibitory receptor. 51
NKG2D down-modulation on human NK cells is followed by DNAM-1 hypo-responsivenss 47
Doxorubicin–Mediated miR–433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR–Independent Manner 47
Samhd1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 47
NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: Role in the NK cell-mediated negative regulation of T cell responses 46
The chemokine receptor CCR8 is preferentially expressed in Th2 but not in Th1 cells 45
null 44
IL-3 induces differentiation and growth of thymocytes and splenic T and B lymphocytes in irradiated mice 42
NKG2D engagement on human NK cells leads to DNAM‐1 hypo‐responsiveness through different converging mechanisms 40
Large−scale profiling of extracellular vesicles identified miR−625−5p as a novel biomarker of immunotherapy response in advanced non−small−cell lung cancer patients 39
In vitro and ex vivo nano-enabled immunomodulation by the protein corona 38
The possible role of sex as an important factor in development and administration of lipid nanomedicine-based COVID-19 vaccine 38
When damage prevents cancer: the activation of the DNA damage response regulate the expression of DNAM-1 and NKG2D activating receptor ligands on human multiple myeloma cells 38
Differential shedding of the MICA and the MICB NKG2D ligands from multiple myeloma cells in response to genotoxic stress 36
Down-regulation of the NKG2D receptor is differentially controlled by MICA and ULBP2 ligands 35
The senescence journey in cancer immunoediting 34
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer 34
Regulation of MICB shedding from multiple myeloma cells in response to genotoxic stress. 33
Down-Regulation of the Activating Receptor NKG2D by its Ligands Expressed on T Lymphocytes: A New Mechanism to Limit CD8+ T Cell Immune Responses. 33
CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma 30
The CD94/NKG2A killer inhibitory receptor inhibits CD69 receptor-induced mast cell degranulation 28
Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues 28
Molecular cloning and expression of cDNA encoding RAT- UDP- N-Acetylglucosamyniltransferase II 26
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells 24
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing 24
Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells 22
null 21
Human NK cells: a new candidate for IL-17 production 20
null 19
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells 17
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition 17
PIGR-enriched circulating vesicles contributes to hepatocellular carcinoma aggressiveness 16
Optimizing transfection efficiency in CAR-T cell manufacturing through multiple administrations of lipid-based nanoparticles 12
null 12
Impact of the protein corona on nanomaterial immune response and targeting ability 12
MICA and ULBP2 differentially regulate NKG2D cell surface expression 11
Rescue SLAMF7 activity in exhausted natural killer cells: Novel challenges in the immunotherapy of multiple myeloma 9
Small extracellular vesicle-delivered microRNAs promote IFN-alpha secretion by plasmacytoid DCs via TLR7 8
Tuning the Orchestra: HCMV vs. Innate Immunity 6
Senescent cells: Living or dying is a matter of NK cells 4
Women in NK and innate lymphoid cell biology 3
Totale 6.143
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.193 0 0 27 122 121 204 182 144 160 128 63 42
2020/2021720 52 62 24 24 20 39 81 26 42 217 60 73
2021/2022861 5 45 112 29 105 27 29 88 72 75 147 127
2022/20231.058 195 273 45 62 110 102 12 72 70 6 50 61
2023/2024847 40 92 44 66 92 155 43 46 26 112 66 65
2024/2025132 56 42 34 0 0 0 0 0 0 0 0 0
Totale 6.143